Podcasts about treatments

Avoidant restrictive food intake disorder (ARFID) is an eating disorder where people severely restrict food due to fear, sensory sensitivities, or low interest — not body image concerns — causing significant health and social problems Unlike normal picky eating, ARFID involves intense distress, extremely narrow food choices, nutritional deficiencies, weight loss, and serious disruption to daily life and social activities Prevalence ranges from 0.35% to 6.4% depending on region, primarily affecting children and teens, with average diagnosis at age 11 and higher male representation than other disorders Treatment approaches include parental control strategies, cognitive behavioral therapy, family-based treatment, food therapy, and sequential oral sensory methods to gradually reduce food-related fear and anxiety A specialized protocol combining psychology, hypnosis, and neuro-linguistic programming shows 90% success for adults and 65% for children, often achieved in single session

 Fertility Docs Uncensored is hosted by Dr. Carrie Bedient from the Fertility Center of Las Vegas, Dr. Susan Hudson from Texas Fertility Center, and Dr. Abby Eblen from Nashville Fertility Center. In this episode, the docs cover everything patients should consider if they plan to start IVF in the next couple of months. They begin with practical but essential advice, especially at the start of a new year, such as re-verification of insurance to ensure the coverage you expect is still in place. They review important lifestyle considerations: diabetes and high blood pressure should be well controlled, weight-loss efforts should begin sooner rather than later if needed, and now is the time to adjust habits or foods that may not support fertility. The doctors discuss the importance of starting supplements early, especially prenatal vitamins, vitamin D, and folic acid, since these nutrients play a critical role even before pregnancy is detected. The team also reviews the value of an up-to-date physical exam and age-appropriate screenings, including mammograms for women over 40. They stress the importance of evaluating the male partner as well, including semen analysis and routine infectious disease testing required by most fertility clinics. Finally, they highlight key pre-IVF testing, such as saline sonograms to assess tubal patency, to ensure patients are ready to begin treatment without delay. Shady Grove Fertility sponsored this podcast. 

My website

My website

Objective data is becoming essential to building trust, reducing bias, and personalizing ADHD care at scale. In this episode, Danielle Vaeth, Head of Strategic Development and Enterprise Sales at Qbtech, discusses how technology is reshaping the assessment and management of ADHD through objective measurement and data-driven insights. She explains why rating scales remain important but incomplete due to bias, stigma, and variability, and how adding objective measures can strengthen clinical confidence, patient trust, and treatment optimization. Danielle examines the gradual yet significant development of behavioral health technology, the impact of access and equity, and the increasing importance of software-driven tools in both urban and rural care settings. She also shares how machine learning and personalized data are shaping the future of ADHD treatment, why measuring outcomes is critical for value-based care, and how aligning incentives across clinicians, patients, and payers can drive better results. Tune in and learn how objective data, technology, and incentives can transform ADHD care over the next five years! Resources: Connect with and follow Danielle Vaeth on LinkedIn. Follow Qbtech on LinkedIn and explore their website.

In this podcast episode, we are joined once again by Dr. Rainey Horwitz, a first-year urology resident at Emory University School of Medicine. She's passionate about sexual health and wellness and is dedicated to destigmatizing conversations about sex between patients and healthcare providers. As a returning guest, Dr. Horwitz brings fresh insights and clinical perspective to an evolving and often misunderstood topic: low sexual desire in men. For more free erectile dysfunction education and resources, please visit: https://eiqmen.com/   Mark Goldberg helps men resolve erectile dysfunction. He offers individual, one-on-one services to men throughout the world through a secure, telehealth platform. It's 100% confidential. You can visit the Center for Intimacy, Connection and Change website to schedule a free consultation: https://centericc.com/

APAC stocks eventually traded mixed after initially taking their cue from Wall Street, although volumes and news flow remained subdued as markets wound down for the holiday period.JPY extended its prior session's advances, and USD/JPY eventually dipped under 156.00, whilst the CNH saw notable strength. US President Trump said the US will keep the ships and oil seized near Venezuela.Novo Nordisk (NOVOB DC) said the Wegovy pill is approved in the US as the first oral GLP-1 treatment for weight management.European equity futures are indicative of an uneventful cash open with the Euro Stoxx 50 U/C after cash closed -0.3% on Monday.Looking ahead, highlights include German Import Prices (Nov), Spanish GDP Final (Q3), US Richmond Fed (Dec), Durable Goods (Oct), GDP Advance (Oct), PCE Prices (Q3), Industrial Production, Consumer Confidence, Canadian GDP, BoC Minutes (Dec Meeting), Supply from US. Click for the Newsquawk Week Ahead.Read the full report covering Equities, Forex, Fixed Income, Commodites and more on Newsquawk

The holiday travel rush gets underway amid severe weather across the U.S. Plus, a swimmer goes missing after a possible shark attack in California. And, new details about Nick Reiner's schizophrenia treatment at the time of his parents' killings. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Fertility treatment can be an emotional rollercoaster, impacting mental health, relationships, and a sense of self. In this episode, Rachel Goldberg, a licensed therapist specializing in infertility and reproductive health, shares practical tips for building resilience, coping with grief, and maintaining connection with partners. She provides insights into navigating the emotional complexities of fertility treatments, pregnancy loss, and family planning while offering actionable strategies to support overall well-being. In this episode we cover: Common emotional challenges people face during fertility treatment  How fertility treatment affects relationships with partners and oneself  Coping strategies for managing stress and anxiety  Prioritizing mental health while staying focused on treatment goals  When to seek support from a mental health professional Read the full show notes on my website. Find Rachel Goldberg's website here.  Do you have questions about IVF? Click here to join me for The IVF Class. The next live class call is on Monday, January 12, 2026, at 4pm PST, where I'll explain IVF and Egg Freezing, and there will be time to ask questions live on Zoom. Other ways to connect: Visit my YouTube channel for more fertility tips! Subscribe to the newsletter to get updates. Join Egg Whisperer School. Request a Consultation with me. Dr. Aimee Eyvazzadeh is one of America's most well-known fertility doctors. Her success rate at baby-making gives future parents hope when all hope is lost. She pioneered the TUSHY Method and BALLS Method to decrease time to pregnancy. Learn more about the TUSHY Method and find a wealth of fertility resources at www.draimee.org.

In this episode, Dr. Nicole Maldonado shares her journey in optometry, focusing on her practice in San Antonio and the integration of IPL technology for dry eye treatment. She discusses the importance of systematic approaches to patient care, the ROI of new equipment, and the significance of tracking patient outcomes. Dr. Maldonado emphasizes the need for courage in implementing new practices and the value of standardizing treatment protocols among practitioners. The conversation highlights the opportunities for optometrists to enhance their practices and better serve patients with dry eye conditions. ------------------- For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table! questions@eyecode-education.com https://coopervision.com/myopia-management Go to MacuHealth.com and use the coupon code PODCAST2024 at checkout for special discounts  Show Sponsors: CooperVision MacuHealth  

Dr. K explains shingles, including why aging increases risk, symptoms and treatment, how it can cause chronic pain, and the many benefits of the shingles vaccine.

Dr. Lisa Duhaime is a board-certified medical oncologist at Peeples Cancer Institute at Hamilton Medical Center in Dalton, Georgia.For more information about Peeples Cancer Institute, call 844-PCI-HOPE or visit VitruvianHealth.com/cancer.This program in no way seeks to diagnose or treat illness or to replace professional medical care. Please see your healthcare provider if you have a health problem.

Share your guest suggestions hereMail - connect@beerbiceps.comLink - https://forms.gle/aoMHY9EE3Cg3Tqdx9Check out BeerBiceps SkillHouse's YouTube 1O1 Course - https://youtube.beerbicepsskillhouse.in/youtube-101BeerBiceps SkillHouse को Social Media पर Follow करे :-YouTube : https://www.youtube.com/channel/UC2-Y36TqZ5MH6N1cWpmsBRQ Instagram : https://www.instagram.com/beerbiceps_skillhouseWebsite : https://beerbicepsskillhouse.inFor any other queries EMAIL: support@beerbicepsskillhouse.comIn case of any payment-related issues, kindly write to support@tagmango.comLevel Supermind - Mind Performance App को Download करिए यहाँ से

Recent preclinical studies highlight the potential of micro‑dosed lithium to modulate Alzheimer's disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer's models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro‑dosing in Alzheimer's care.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Clinical Editor, CEimpactLead Editor, PyrlsGUESTDawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFHProfessor of Pharmacy PracticeMidwestern UniversityPRACTICE RESOURCEPurchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation:If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current evidence on the use of microdose lithium in Alzheimer's disease.2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer's.Rachel Maynard and Dawn Gerber have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-25-375-H01-PInitial release date: 12/22/2025Expiration date: 12/22/2026Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram

Welcome to "Labor & Delivery Debrief," the podcast where we tackle your toughest questions about childbirth and maternal health. Today, we're diving deep into a fascinating and critical topic sent in by one of our listeners, Sarah. Sarah asks: "Is it possible for a clinical diagnosis of chorioamnionitis to not be confirmed by placental histology? And if so, how is that possible?" This is a fantastic question that touches on the complexities of intrapartum clinical diagnosis of intraamniotic infection (IAI), also commonly known as chorioamnionitis. We'll explore the nuances of clinical versus histological findings, the diagnostic criteria, and why these two assessments don't always perfectly align. Get ready for a detailed discussion that will shed light on this important aspect of obstetric care.1. ACOG CO 712; 2017 (2025)2. Romero R, Pacora P, Kusanovic JP, et al. Clinical Chorioamnionitis at Term X: Microbiology, Clinical Signs, Placental Pathology, and Neonatal Bacteremia - Implications for Clinical Care. Journal of Perinatal Medicine. 2021;49(3):275-298. doi:10.1515/jpm-2020-0297.3. Jung E, Romero R, Suksai M, et al. Clinical Chorioamnionitis at Term: Definition, Pathogenesis, Microbiology, Diagnosis, and Treatment. AJOG. 2024;230(3S):S807-S840. doi:10.1016/j.ajog.2023.02.002.4. Oh KJ, Kim SM, Hong JS, et al. Twenty-Four Percent of Patients With Clinical Chorioamnionitis in Preterm Gestations Have No Evidence Of either Culture-Proven Intraamniotic Infection Or intraamniotic Inflammation. AJOG. 2017;216(6):604.e1-604.e11.

Send us a textTreatment of Hypotension of Prematurity: a randomised trial.Alderliesten T, Arasteh E, van Alphen A, Groenendaal F, Dudink J, Benders MJ, van Bel F, Lemmers P. Arch Dis Child Fetal Neonatal Ed. 2025 Dec 15;111(1):F60-F66. doi: 10.1136/archdischild-2024-328253.PMID: 40413017 Clinical Trial.Support the showAs always, feel free to send us questions, comments, or suggestions to our email: nicupodcast@gmail.com. You can also contact the show through Instagram or Twitter, @nicupodcast. Or contact Ben and Daphna directly via their Twitter profiles: @drnicu and @doctordaphnamd. The papers discussed in today's episode are listed and timestamped on the webpage linked below. Enjoy!

In this episode of the Oncology Brothers podcast, we dived into the latest discussions surrounding metastatic colorectal cancer, focusing on treatment strategies for refractory cases. We recapped our recent discussions with GI experts, including Dr. John Strickler, Dr. Chiara Cremolini, Dr. Namrata Vijayvergia, and Dr. Tiago Biachi. Key topics included: * The importance of next-generation sequencing (NGS) and biomarker testing in treatment planning. * An overview of second-line treatment options such as Tas-102 with Bevacizumab, Regorafenib, and Fruquintinib, along with their respective clinical trial data. * Insights into side effect management and quality of life considerations for patients undergoing palliative treatment. * A discussion on the recent STELLAR-303 study and its implications for immunotherapy in colorectal cancer. Join us as we bridge the gap between academia and community practice, emphasizing the need for improved treatment options and patient care in the realm of refractory colorectal cancer. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more practice-changing updates! #ColorectalCancer #mCRC #TAS102 #Regorafenib #PalliativeCare #OncologyBrothers #GIOcology

Nicola Longo MD, PhD, and Mark Roberts, MDDrs. Longo and Roberts discuss the current status of gene therapies in rare neuromuscular disorders in this eight-part podcast series. This is derived from the symposium that was presented at WORLDSymposium 2025 in San Diego, California on February 4th-7th 2025 and is intended for healthcare professionals only.This podcast includes information about investigational compounds that do not yet have a regulatory approval or authorization for a specific indication. The safety and efficacy of the agents under investigation have not been established and contents of this podcast shall not be used in any manner to directly or indirectly promote or sell the product for unapproved uses.The views, thoughts, and opinions expressed in this presentation belong solely to the author and are subject to change without notice. The contents of this presentation do not constitute an endorsement of any product or indication by Astellas. In this part, Dr. Longo will discuss the current treatment landscape and limitations in lysosomal disorders.Nicola Longo MD, PhDWhat I want to do today, is just place gene replacement therapy within the current landscape of lysosomal storage disorder treatment therapy. Gene therapy obviously has the potential of treating lysosomal disorder to correct the root cause of lysosomal storage disorder. The gene is defective, and what happen is that you can potentially either fix the gene or bypass the lack of the genetic product. But there are already therapies that are existing and are functioning. Obviously, in many cases, the lysosomal disorder is caused by defective production of an enzyme, which is defective.We can either replace the enzyme with enzyme replacement therapy, or provide chaperone for specific mutations that retain the synthesis of the enzyme, that however is not very functional. Another avenue that it is being reported is the utilization of substrate reduction therapy. A substrate accumulates, you prevent the synthesis of the substrate to reduce the accumulation of toxic material. What we know now is that this is not enough to produce many lysosomal disorders. In many cases, the lysosomal disorder result sometime in impairment of intracellular trafficking, and sometime in the function of other organelles.At the end, it results in the activation of the macrophagic system and inflammation. Already we have some therapy acting at this level. The end result of lysosomal storage disorder, there will be cell suffering and cell death, leading to a progression of the disease, and morbidity and mortality. Now, what therapy do we have available already? Obviously, hematopoietic stem cell transplantation has been around for quite some time.It has been the same thing that we do with gene therapy, except that instead of reintroducing the gene of the subject, we place gene of a subject who is not affected of the disease. This therapy has been proven effective in cases of MPS-1 and alpha-mannosidosis. But in many cases this has to be given way before symptoms start to be affected.Enzyme replacement therapy has been around for quite some time, starting with Gaucher disease, and now that it is available for a list of diseases that are there, so it's like Fabry, Gaucher, Pompe, different types of mucopolysaccharidosis, alpha-mannosidosis, acid lipase deficiency, 1 neuronal ceroid lipofuscinosis, and Niemann-Pick type A and B.Obviously the advantage of this therapy, they give back the enzyme that it is defective. But the disadvantage that many time they cannot enter specialized areas such as the brain. There is already the second generation of enzyme replacement therapy that it is available. With this second generation, some of the newer drugs are more effective in terms of cellular uptake, or in terms of having a prolonged half-life and prolonged activity.Then there are pharmacological chaperone therapy, and the one which is FDA approved is migalastat for Fabry disease, under study is ambroxol for Gaucher disease. The disadvantage of this therapy that only a selected number of mutations respond to this therapy.Substrate reduction therapy has been introduced for Gaucher disease many years ago with miglustat, and it was followed by eliglustat. Both of them are effective, and some of them more effective than other, simply because of the fewer side effects of eliglustat as compared to miglustat. But at the same time, eliglustat does not pass the blood brain barrier.Finally, the newer agents that are already administered, N-acetyl-L-leucine and arimoclomol, both approved for Niemann-Pick type C, they act more on the downstream effect of the lysosomal storage disorder, either by stabilizing neuronal cell activity or by reducing the inflammation that is present in the brain.In the next part, Dr. Longo will discuss gene replacement therapy in lysosomal disorders.

Vol. 4 of Story Time, a new series on the program featuring an author reading aloud from her work. In this episode, Jeannie Vanasco reads from her new memoir A Silent Treatment, available from Tin House. Official December pick of the Otherppl Book Club. Jeannie's other memoirs are Things We Didn't Talk About When I Was a Girl and The Glass Eye. Born and raised in Sandusky, Ohio, she lives in Baltimore and is an associate professor of English at Towson University. *** ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Otherppl with Brad Listi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ is a weekly podcast featuring in-depth interviews with today's leading writers. This episode is sponsored by Ulysses. Go to ⁠⁠ulys.app/writeabook⁠⁠ to download Ulysses, and use the code OTHERPPL at checkout to get 25% off the first year of your yearly subscription." Available where podcasts are available: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Apple Podcasts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Spotify⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, etc. Get ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠How to Write a Novel,⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ the debut audio course from DeepDive. 50+ hours of never-before-heard insight, inspiration, and instruction from dozens of today's most celebrated contemporary authors. Subscribe to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Brad's email newsletter⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Support the show on Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Merch⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Bluesky⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Email the show: letters [at] otherppl [dot] com The podcast is a ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠proud affiliate partner of Bookshop⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, working to support local, independent bookstores. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Ben hosts Dr. Tricia to break down what works best for tinnitus relief. Cognitive Behavioral Therapy, sound therapy, and expert guidance come together. Learn the top strategies backed by science and clinical success.Get started with Treble Health:Schedule a complimentary telehealth consultation: treble.health/free-telehealth-consultation Take the tinnitus quiz: https://treble.health/tinnitus-quiz-1Download the Ultimate Tinnitus Guide: 2024 Edition: https://treble.health/tinnitus-guide-2025

George processes some of his experiences with the therapies and supports that we previously discussed, then describes more esoteric approaches that he has found beneficial very recently. We are here to share our entire intersectional experience with anyone who finds it beneficial, but we want to know what you connect with the most. You can let us know by clicking to a one-question anonymous survey at vote.pollcode.com/32371374. If you have a request/suggestion that isn't listed, comment! We can be found online at TransPanTastic.net, you can email us at TransPanTastic@gmail.com, and "TransPanTastic" is searchable on most social networks. We would love to hear from you, so let us know what you think or what you want to hear about!

igraine disorders affect more than 1 billion people across the globe, yet they remain deeply misunderstood. In this episode, I sit down with Dr. Adam Harcourt to explore the true nature of migraines as a genetic neurological condition and to uncover why so many patients struggle to find lasting relief. Together, we examine the roots of migraine expression, including genetic vulnerability, environmental triggers, hormonal shifts, and the lifestyle factors that amplify neurological stress. Our conversation also dives into the complex relationship between concussion and migraine. These conditions often overlap, or they are mistaken for one another, which can delay the right treatment. Dr. Harcourt explains how functional neurological assessments can help clinicians identify the specific pathways involved and create targeted strategies that match the needs of each patient. We then discuss one of the most promising tools in migraine care: low-level laser therapy. Dr. Harcourt outlines how laser applications can reduce inflammation, support neural recovery, and help patients build resilience against recurring episodes. This episode offers science, clarity, and practical hope for anyone who lives with migraines or treats them in clinical practice.   Key takeaways: Genetic Disposition and Migraine: Migraines are primarily genetically mediated neurological disorders, with significant variations in expression and symptoms, often unrelated to pain. The Bucket Theory: Dr. Harcourt explains how stressors fill up a "bucket," causing migraines when they overflow, highlighting the need for both reducing stressors and expanding the "bucket." Concerns of Misdiagnosis: Many individuals are misdiagnosed with migraine when they may be suffering from post-concussion syndrome, underscoring the importance of precise diagnosis. Therapeutic Innovations: The discussion highlights the potential of low-level laser therapy in treating migraines, offering a non-invasive alternative to Botox and medication. Holistic Approach to Treatment: Emphasizing diet, hormone balance, and neuro-rehabilitation, Dr. Harcourt advocates for an integrated approach to effectively manage and prevent migraines. More About Dr. Adam Harcourt:   Dr. Adam Harcourt is the owner of Harcourt Brain Center currently located in York, PA, with offices formerly in Santa Barbara and Beverly Hills  CA. He is a Fellow of the American College of Functional Neurology (FACFN), Fellow of the American Board of Vestibular Rehabilitation (FABVR), Diplomate of the American Chiropractic Neurology Board (DACNB), and a 4th generation Doctor of Chiropractic. Dr. Harcourt is also an Associate Professor of Clinical Neurology at Carrick Institute for Graduate Studies, where he developed a 150-hour post-doctoral program,  titled 'Mastering Migraine', with which he instructs doctors from all different backgrounds from around the world. Website Instagram Connect with me! Website Instagram Facebook YouTube

Sign up to Easy Ayurveda Video Classes by clicking the link belowhttps://www.easyayurveda.com/video-classes/Video Course: “Ayurvedic food and Nutrition”https://www.easyayurveda.com/nutrition/Buy Tridosha Made Easy Bookhttps://www.easyayurveda.com/tridosha-made-easy-3/Buy Tridosha Made Easy Book in Spanish LanguageEl corazón de los doshas: Nuevo librohttps://www.easyayurveda.com/el-corazon-de-los-doshas/Click to know more about Easy Ayurveda Hospitalhttps://www.easyayurveda.com/hospital/Buy our new course on Marma Therapy Part 1https://www.easyayurveda.com/marma1Buy our new course on Marma Therapy Part 1Subscribe to Easy Ayurveda Video Classes https://www.easyayurveda.com/video-classes/Subscribe to our free Easy Ayurveda newsletter here (you can unsubscribe and stop them anytime) -  https://forms.aweber.com/form/58/2129766958.htm Buy our course on diabetes reversal, powered by Madhavbaug https://www.easyayurveda.com/diabetes Buy our online video course on Treatment of cardiac disorders with Ayurveda https://www.easyayurveda.com/heartMaster ECG in one week. Sign up for video course https://www.easyayurveda.com/ecgContact Dr. MB Gururaja BAMS MD (Ayu)https://www.easyayurveda.com/gururaja  Contact Dr. Raghuram YS BAMS MD (Ayu)https://www.easyayurveda.com/raghuram Buy Easy Ayurveda Ebooks https://www.easyayurveda.com/my-book Buy Easy Ayurveda Printed Books https://www.easyayurveda.com/books/

Acute Coronary Syndrome refers to a spectrum of conditions including Unstable Angina, Non ST Elevation Myocardial Infarction and ST Elevation Myocardial Infarction. In this video we look at the pathology behind acute coronary syndrome, the differences between Unstable angina, NSTEMI and STEMI, as well as the signs and symptoms, diagnosis (including ECG changes!) and treatment of each. PDFs available here: https://rhesusmedicine.com/pages/cardiologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Buy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Acute Coronary Syndrome - Acute Coronary Syndrome Definition0:25 Coronary Artery Anatomy1:17 Acute Coronary Syndrome Pathology - Atherosclerosis 2:08 Acute Coronary Syndrome Pathology - Unstable Angina vs Non ST Elevation Myocardial Infarction vs ST Elevation Myocardial Infarction3:00 Acute Coronary Syndrome Risk Factors3:23 Signs and Symptoms of Acute Coronary Syndrome4:17 Acute Coronary Syndrome Diagnosis - ECG STEMI5:45 Acute Coronary Syndrome Diagnosis - ECG NSTEMI and Unstable Angina6:42 Acute Coronary Syndrome Diagnosis - Cardiac Troponin I 7:11 Acute Coronary Syndrome Diagnosis - Imaging7:42 Treatment of Acute Coronary SyndromeLINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesBritish National Formulary (BNF), 2015. Acute coronary syndromes – treatment summary. [online] Available at: https://bnf.nice.org.uk/treatment-summary/acute-coronary-syndromes.html. BNFTeachMeAnatomy, 2025. Heart vasculature. [online] Available at: https://teachmeanatomy.info/thorax/organs/heart/heart-vasculature/. TeachMeAnatomy+1DeVon, H.A., 2020. Typical and atypical symptoms of acute coronary syndrome. Journal of the American Heart Association, 9:e015539. [online] Available at: https://www.ahajournals.org/doi/10.1161/JAHA.119.015539. AHA JournalsWarren, A., 2020. Acute coronary syndrome: risk factors, diagnosis and treatment. The Pharmaceutical Journal. [online] Available at: https://pharmaceutical-journal.com/article/ld/acute-coronary-syndrome-risk-factors-diagnosis-and-treatment. The Pharmaceutical JournalLife in the Fast Lane (LITFL), 2021. Acute coronary syndromes. [online] Available at: https://litfl.com/acute-coronary-syndromes/. Life in the Fast Lane • LITFLDisclaimer: Please remember this podcast and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

Myopericarditis includes both myocarditis and pericarditis. In this video we cover what is myopericarditis, as well as causes of myocarditis and pericarditis, signs and symptoms of pericarditis and myocarditis, as well as the diagnosis and treatment. PDFs available here: https://rhesusmedicine.com/pages/cardiologyConsider subscribing (if you found any of the info useful!): https://www.youtube.com/channel/UCRks8wB6vgz0E7buP0L_5RQ?sub_confirmation=1Buy Us A Coffee!: https://www.buymeacoffee.com/rhesusmedicineTimestamps:0:00 What is Myopericarditis? (What is Myocarditis / What is Pericarditis?)0:15 Anatomy - Pericardium & Layers of the Heart 1:41 Infectious Causes of Myocarditis / Pericarditis 2:31 Non Infectious Causes of Myocarditis / Pericarditis 3:22 Signs and Symptoms4:19 Diagnosis of Myopericarditis5:45 Treatment of Myocarditis and Pericarditis LINK TO SOCIAL MEDIA: https://www.instagram.com/rhesusmedicine/ReferencesMSD Manuals Professional, 2025. Myocarditis – Cardiovascular Disorders. [online] Available at: https://www.msdmanuals.com/professional/cardiovascular-disorders/myocarditis-and-pericarditis/myocarditis. Reviewed/Revised May 2024; Modified Oct 2025. MSD ManualsManda, Y. & Baradhi, K., 2023. Myopericarditis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. [online] Available at: https://www.ncbi.nlm.nih.gov/books/NBK534776/. NCBIWikipedia, 2025. Myopericarditis. [online] Available at: https://en.wikipedia.org/wiki/Myopericarditis. en.wikipedia.orgDisclaimer: Please remember this video and all content from Rhesus Medicine is for educational and entertainment purposes only and is not a guide to diagnose or to treat any form of condition. The content is not to be used to guide clinical practice and is not medical advice. Please consult a healthcare professional for medical advice.

My website

In the 5 AM hour, Larry O’Connor and Patrice Onwuka discussed: KENNEDY CENTER RENAME: Trump's Handpicked Kennedy Center Board Votes to Rename It the 'Trump-Kennedy Center' GENDER BILLS: House Passes Marjorie Taylor Greene’s Bill to Criminalize Transgender Surgeries on Minors HHS ON TRANS TREATMENTS: Current Evidence Does Not Support Claims That Puberty Blockers, Cross-Sex Hormones, and Surgeries Are Safe and Effective Treatments for Pediatric Gender Dysphoria Where to find more about WMAL's morning show: Follow Podcasts on Apple Podcasts, Audible and Spotify Follow WMAL's "O'Connor and Company" on X: @WMALDC, @LarryOConnor, @JGunlock, @PatricePinkfile, and @HeatherHunterDC Facebook: WMALDC and Larry O'Connor Instagram: WMALDC Website: WMAL.com/OConnor-Company Episode: Friday, December 19, 2025 / 5 AM HourSee omnystudio.com/listener for privacy information.

Dr. Tricia Scaglione from Treble Health Weston explains the three key components of tinnitus treatment that truly work. She breaks down sound therapy, cognitive behavioral therapy, and mindfulness for lasting relief. Learn how combining these approaches can reduce tinnitus distress and restore balance.Get started with Treble Health:Schedule a complimentary telehealth consultation: treble.health/free-telehealth-consultation Take the tinnitus quiz: https://treble.health/tinnitus-quiz-1Download the Ultimate Tinnitus Guide: 2024 Edition: https://treble.health/tinnitus-guide-2025

In this episode of the Oncology Brothers podcast, we are joined by Dr. Komal Jhaveri, a breast medical oncologist at Memorial Sloan Kettering, to discuss the evolving landscape of metastatic hormone receptor positive breast cancer, particularly focusing on low and ultra-low HER2 expression. Key topics include: • The significance of the DESTINY Breast-04 and DESTINY Breast-06 studies and their impact on treatment options. • The definition and implications of low and ultra-low HER2 expression in clinical practice. • The importance of HER2 testing and the dynamic nature of HER2 expression in tumors. • Treatment sequencing strategies, including the use of antibody-drug conjugates (ADCs) like trastuzumab deruxtecan (TDXd) and sasituzumab govitecan. • Management of treatment-related toxicities, including ILD, nausea, and alopecia. Join us for an insightful discussion that aims to keep healthcare professionals updated on the latest advancements in cancer care. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for more episodes and insights!

On this episode of the Sports Medicine Primer Series, host Dr. Zainab Shirazi, MD, continues the conversation with Dr. Adam Tenforde, MD, discussing how to manage a case of hip pain in a 25-year-old recreational weightlifter. The goal of this ongoing series is to provide an audio study aid for anyone pursuing a career as a sports medicine physician and to prepare them for a sports medicine fellowship. Dr. Tenforde is an assistant professor in the Department of Physical Medicine and Rehabilitation at Harvard Medical School. He is a sports medicine physician at the Spaulding National Running Center – one of the only centers in the United States exclusively dedicated to the diagnosis and treatment of running-related injuries. He has the unique perspective of being both a doctor and a former professional runner who was an All-American at Stanford University, where he contributed to three NCAA National Team Championships and later qualified for the Olympic trials. Dr. Shirazi is an Attending Physician at Women's Health, Sports & Performance (WHSP) Medical in Brighton, MA, and a dual board-certified physician in Sports Medicine and Physical Medicine & Rehabilitation. She has a passion for advancing the health and performance of female athletes and specializes in the non-operative management of musculoskeletal and sports-related injuries, providing comprehensive care for athletes of all ages and abilities.   Resources Mountjoy M, Ackerman KE, Bailey DM, et al. 2023 International Olympic Committee's (IOC) consensus statement on Relative Energy Deficiency in Sport (REDs). Br J Sports Med. 2023;57(17):1073-1097. doi:1136/bjsports-2023-106994 Kraus E, Tenforde AS, Nattiv A, et al. Bone stress injuries in male distance runners: higher modified Female Athlete Triad Cumulative Risk Assessment scores predict increased rates of injury. Br J Sports Med. 2019;53(4):237-242. doi:1136/bjsports-2018-099861 Hoenig T, Ackerman KE, Beck BR, et al. Bone stress injuries. Nat Rev Dis Primers. 2022;8(1):26. doi:1038/s41572-022-00352-y Nattiv A, Kennedy G, Barrack MT, et al. Correlation of MRI grading of bone stress injuries with clinical risk factors and return to play: a 5-year prospective study in collegiate track and field athletes. Am J Sports Med. 2013;41(8):1930-1941. doi:1177/0363546513490645 Hoenig T, Tenforde AS, Strahl A, Rolvien T, Hollander K. Does Magnetic Resonance Imaging Grading Correlate With Return to Sports After Bone Stress Injuries? A Systematic Review and Meta- analysis. Am J Sports Med. 2022;50(3):834-844. doi:1177/0363546521993807 Barrack MT, Fredericson M, Tenforde AS, Nattiv A. Evidence of a cumulative effect for risk factors predicting low bone mass among male adolescent athletes. Br J Sports Med. 2017;51(3):200-205. doi:1136/bjsports-2016-096698 Robertson GA, Wood AM. Femoral Neck Stress Fractures in Sport: A Current Concepts Review. Sports Med Int Open. 2017;1(2):E58-E68. doi:1055/s-0043-103946 Fredericson M, Roche M, Barrack MT, et al. Healthy Runner Project: a 7-year, multisite nutrition education intervention to reduce bone stress injury incidence in collegiate distance runners. BMJ Open Sport Exerc Med. 2023;9(2):e001545. doi:1136/bmjsem-2023-001545 Roche M, Nattiv A, Sainani K, et al. Higher Triad Risk Scores Are Associated With Increased Risk for Trabecular-Rich Bone Stress Injuries in Female Runners. Clin J Sport Med. 2023;33(6):631-637. doi:1097/JSM.0000000000001180 Burke LM, Ackerman KE, Heikura IA, Hackney AC, Stellingwerff T. Mapping the complexities of Relative Energy Deficiency in Sport (REDs): development of a physiological model by a subgroup of the International Olympic Committee (IOC) Consensus on REDs. Br J Sports Med. 2023;57(17):1098-1108. doi:1136/bjsports-2023-107335 Tenforde AS, Barrack MT, Nattiv A, Fredericson M. Parallels with the Female Athlete Triad in Male Athletes. Sports Med. 2016;46(2):171-182. doi:1007/s40279-015-0411-y Hoenig T, Eissele J, Strahl A, et al. Return to sport following low-risk and high-risk bone stress injuries: a systematic review and meta-analysis. Br J Sports Med. 2023;57(7):427-432. doi:1136/bjsports-2022-106328 Nattiv A. Stress fractures and bone health in track and field athletes. J Sci Med Sport. 2000;3(3):268-279. doi:1016/s1440-2440(00)80036-5 Nattiv A, Armsey TDJ. Stress injury to bone in the female athlete. Clin Sports Med. 1997;16(2):197-224. doi:1016/s0278-5919(05)70017-x Nattiv A, De Souza MJ, Koltun KJ, et al. The Male Athlete Triad-A Consensus Statement From the Female and Male Athlete Triad Coalition Part 1: Definition and Scientific Basis. Clin J Sport Med. 2021;31(4):335-348. doi:1097/JSM.0000000000000946 Fredericson M, Kussman A, Misra M, et al. The Male Athlete Triad-A Consensus Statement From the Female and Male Athlete Triad Coalition Part II: Diagnosis, Treatment, and Return-To-Play. Clin J Sport Med. 2021;31(4):349-366. doi:1097/JSM.0000000000000948

ChristianaCare researchers make a breakthrough in lung cancer care.The breakthrough reverses chemotherapy resistance, and the hope is this research will help develop the same results for other cancers in the future.In this edition of Enlighten Me, Delaware Public Media's Joe Irizarry talks with Kelly Banas, the lead author of the study and associate director of research at the ChristianaCare Gene Editing Institute about the importance of the findings and what might come next.

Atomoxetine is a selective norepinephrine reuptake inhibitor prescribed for the management of attention-deficit hyperactivity disorder (ADHD).  In this podcast, Emily Yamada discusses her article "Atomoxetine as a Viable ADHD Treatment in Breastfeeding Mothers: Evidence From Human Milk Pharmacokinetic Analysis." In their article, Yamada and her colleagues present data showing that there is minimal transfer of atomoxetine in breast milk, suggesting that maternal atomoxetine use poses a very low risk to breastfed infants, making it a suitable choice for medication management of ADHD in lactating women. The other contributing authors are Shraddha Trehan, Amy Stark, Kaytlin Krutsch, and Palika Datta. The article is published in the January-February 2026 issue of The Journal of Clinical Psychopharmacology. doi: 10.1097/JCP.0000000000002109

Treatment-resistant depression (TRD) is a considerable clinical challenge. Esketamine, in conjunction with an oral antidepressant, is a potential treatment for TRD. In this podcast, Dr. Matteo Lupi discusses his article, "Esketamine and Quality of Life Improvement in Treatment-Resistant Depression Patients: A Real-World Clinical Study." The prospective study described in the report explores the long-term effects of esketamine therapy on subjective quality of life in adults with TRD.   The other contributing authors are Alessandro Carano, Tiziano Acciavatti, Stefano Marini, Marco Palmucci, Elicio Marinucci, Enrico Paolini, Alessandro Gentile, Angelomarco Barioglio, Marco Giri, Domenico De Berardis, and Giovanni Martinotti. The article is published in the January-February 2026 issue of The Journal of Clinical Psychopharmacology. doi: 10.1097/JCP.0000000000002042

Angelina Kelly, Alex Crook and Gabby Agbonlahor bring you the second episode of a brand new talkSPORT Daily Christmas Series - The 12 Hot Takes of Xmas.Three of our wisest presenters and pundits, each deliver one blazing-hot take per episode. That's three HUGE opinions a day… twelve in total… and absolutely no fear of things getting a little heated!In today's episode they delve into whether Mo Salah is receiving too much heat for his interview calling out his treatment at Liverpool, whether Ruben Amorim's treatment of Kobbie Mainoo is betraying the roots of Man United AND decide whether Wolves could be the single worst team we've ever seen in the Premier League!Photo Credit: Getty Images Hosted on Acast. See acast.com/privacy for more information.

Support your health journey with our private practice! Explore comprehensive lab testing, functional assessments, and expert guidance for your wellness journey. Find exclusive offers for podcast listeners at nutritionwithjudy.com/podcast. _____Dr. Neil and I dive deep into the differences between mold illness and Chronic Inflammatory Response Syndrome (CIRS), exploring why not all patients respond to the same protocols. We also break down the role of nervous system dysregulation, especially the limbic and vagal systems, in patients who stay sick despite detox protocols. Make sure to watch the full interview to learn more.Dr. Neil Nathan, MD, is a seasoned physician board‑certified in family medicine and pain management, and a founding diplomate of the American Board of Integrative Holistic Medicine (ABoIHM). He has authored books such as Toxic: Heal Your Body and focuses on treating complex chronic conditions including environmental illness, mold toxicity, Lyme disease, mast cell activation and more.We discuss the following:All about Dr. Neil NathanWhat to address first when starting a protocolUse of urine mycotoxin testingActinos discussionUrinary mycotoxin testing approachClean environment standardsUse of antifungalsPreferred mycotoxin testing labDr. Shoemaker perspective on antifungalsEvaluating antifungal optionsWhere to find Dr. Neil Nathan_____EPISODE RESOURCESWebsiteToxic bookThe Sensitive Patient's Healing GuideProject LymeDr. Neil Nathan on Mold and MCAS with Dr. Tania DempseyWhen You're Not Getting Better blogNwJ Actinos articleEFH Personalized Health PlanEFH CIRS TestingEFH CIRS Environment ERMI Guide Bundle_____WEEKLY NEWSLETTER 

Your very own To Save Us From Hell co-host Anjali Dayal briefed the United Nations Security Council on Monday! She was paired with former UN Secretary-General Ban Ki-moon for a special meeting of the Council dedicated to examining the role of the Secretary-General and the process for selecting Antonio Guterres's successor. Anjali gives co-host Mark Leon Goldberg a behind-the-scenes account of what it's like to sit in the briefers' chair at the famous horseshoe table and shares highlights from the meeting. After the paywall, Mark and Anjali discuss a glowing New Yorker profile of International Atomic Energy Agency chief—and UN Secretary-General candidate—Rafael Grossi. It's certainly a PR coup for the Argentine, but does PR really matter when it comes to running for UN Secretary-General? We discuss! And one more thing: this is the 50th episode of To Save Us From Hell. Fifty episodes of deep dives into power, politics, and the UN's place in the world. Huge thanks to everyone who listens—and especially to our paid subscribers, who make this show possible. If you've been on the fence, now's the moment: grab a paid subscription using the discount link below, get access to our full episodes and support the show with a cult following around the UN! https://www.globaldispatches.org/40percentoff 

Y'all, my guest today, Toni Becker is absolutely incredible.Toni lives in South Africa and is a content creator with twelve years sober. Toni was plagued by disordered eating years before her addictions to meth and alcohol began. Years of partying led to homelessness, meth psychosis and severe illness and kidney failure. In sobriety, Toni was still struggling with disordered eating. Treatment in sobriety finally helped her with that struggle. Later in sobriety, she developed facial dysmorphia induced by social media expectations and filters. Talking about these issues in sobriety was fascinating and I learned so much from Toni!Connect with Toni on ⁠Instagram⁠DM me on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Message me on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Facebook⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Listen AD FREE & workout with me on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Patreon⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Connect with me on ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Email me chasingheroine@gmail.comSee you next week!

Send us a textAbout Dr. Kathryn Richdale:Dr. Kathryn Richdale received her BS from the University of Notre Dame and her OD, PhD, and Cornea and Contact Lens Advanced Practice Fellowship from The Ohio State University. She was founding director of the Clinical Vision Research Center, and established the Myopia Control Clinic at the State University of New York College of Optometry before joining the University of Houston College of Optometry (UHCO) as an Associate Professor in 2017. Dr. Richdale is an attending in the Cornea and Contact Lens Service, oversees the Myopia Management Service, and teaches in both the optometric and graduate programs at UHCO. She conducts research and teaches primarily in the areas of cornea, contact lenses and refractive error. Dr. Richdale earned her Diplomate in the American Academy of Optometry Cornea, Contact Lenses and Refractive Technologies section in 2019 and is currently a board member for our Academy's journal (OVS) and Foundation.---If you're considering or have ever considered getting a virtual team member for your practice check out hiredteem.com, mention The Myopia Podcast when signing up for a $250 dollar discount off of your first month's teem member.https://hireteem.com/myopia-podcast/

Send us a textA lot of parents have difficulty to understand that just because they have Myopia, that doesn't mean their children will. However it's proven that genetics is one factor, and there are some significant others like amount of time spent near and far from a screen, education levels etc. I've had 15 years in my practice talking with parents about the importance of their children having regular eye exams and making them aware of the technological advances in this field. On today's episode of The Myopia Podcast, I will share with you some treatment options for Myopia and how you can present them to parents effectively. 

Chad Gordon radiated positivity when talking about his daughter Adley's successful battle with B Cell Acute Lymphoblastic Leukemia which began just before her 2nd birthday in  February of 2022, and ended 800 days later when she was able to Ring the Bell at Penn State's Hersey Children's Hospital. Chad talks about what Adley went through, and also how the THON event which is a very well known Dance Marathon at Penn State, and the Four Diamonds Childhood Cancer Organization did so much to help Adley and the Gordon Family.

Welcome back to the Oncology Brothers podcast! In this episode, we continue the CME series on HER2-positive GEJ and gastric cancer, shifting focus to the essential topic of treatment toxicity management. We're joined by two leading experts: Dr. Geoffrey Ku from Memorial Sloan Kettering and Dr. Shruti Patel from Stanford University. Building on their previous discussion of upper GI treatment algorithm with Dr. Rutika Mehta, this episode delves into the practical realities of managing patients on complex regimens. Drs. Ku & Patel break down the side effect profiles across the treatment continuum—from frontline trastuzumab-based combinations to emerging therapies like zanidatamab—and provide actionable strategies for community oncologists. Episode Highlights: • Practical management of frontline side effects with FOLFOX/XELOX chemotherapy plus trastuzumab and pembrolizumab • Reality check on trastuzumab cardiotoxicity: incidence rates and monitoring protocols in gastric vs. breast cancer • Immune-related adverse events with checkpoint inhibitors: what's common vs. rare in GI cancers • Critical insights on zanidatamab's synergistic diarrhea toxicity and mandatory prophylaxis strategies • TDXd (Enhertu) in second-line: moving beyond ILD fears to address frequent cytopenias and marrow management • Expert consensus on infusion reaction management for novel biologics • The importance of managing baseline symptoms in patients with dysphagia and nausea This episode bridges the gap between trial data and clinical practice, offering real-world wisdom on keeping patients on effective therapies through proactive toxicity management. Follow us on social media: •⁠  ⁠X/Twitter: https://twitter.com/oncbrothers •⁠  ⁠Instagram: https://www.instagram.com/oncbrothers •⁠  Website: https://oncbrothers.com/ Don't forget to subscribe for our complete CME series covering treatment algorithms, FDA approvals, and practical management strategies! Accreditation/Credit Designation Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Physicians' Education Resource®, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Acknowledgment of Commercial Support This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc. Link to gain CME credits from this activity: https://www.gotoper.com/courses/navigating-the-adverse-event-landscape-in-her2-gea-therapy

On this episode of The Mark White Show, Dr. Diana Bitner, board certified OB GYN and Certified Menopause Society Practitioner, joins veteran news anchor and patient advocate Wendee Lee Curtis for an open conversation about moderate to severe hot flashes due to menopause. They discuss what these symptoms can feel like, why many women are unprepared for their impact, and the importance of talking with a healthcare professional. The conversation also includes information about Lynkuet® (elinzanetant), a newly FDA approved, hormone free treatment option for moderate to severe hot flashes due to menopause. This episode focuses on awareness, understanding, and informed conversations between women and their doctors. These guests appear on behalf of Bayer and have been compensated for their time.

This is a free preview of a paid episode. To hear more, visit www.globaldispatches.orgDiscount link for full episode: https://www.globaldispatches.org/40percentoff Your very own To Save Us From Hell co-host Anjali Dayal briefed the United Nations Security Council on Monday! She was paired with former UN Secretary-General Ban Ki-moon for a special meeting of the Council dedicated to examining the role of the Secretary-General and the process for selecting Antonio Guterres's successor. Anjali gives co-host Mark Leon…

The addiction recovery program in Gardner, Mass., is part animal sanctuary, part therapy center. The men who stay there get assigned to care for one of dozens of animals — from chickens, pigs, goats and even ponies — as part of their treatment.

Gregory Copley. Gregory Copley discusses King Charles's recent video regarding his cancer, noting the King implied success with early detection and a reduction in future treatments. Dismissing social media panic, Copley explains the King remains in command and is more likely to die with the disease than of it.

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

Send us a textCrises rarely look like TV. Most calls aren't bank robberies; they're frantic welfare checks, neighbor standoffs over fences, a parent terrified for a missing teen, or someone hearing voices at 2 a.m. We sit down with Dr. Sarah Abbott, a pioneer of the police–clinician co-response model, to unpack how pairing a trained clinician with officers at the point of contact reshapes outcomes: fewer arrests, fewer injuries, and far more dignity for the person in distress.Sarah shares the origin story from Massachusetts, where “jail diversion” began as a humane alternative for low-level offenses tangled with mental illness and grew into a comprehensive crisis response approach now spreading nationally and internationally. We get honest about the early skepticism and what changed minds: consistent data, strong command support, and the day-to-day reality that most police work involves behavioral health, not crime. We also go inside Section 12—involuntary transport in Massachusetts—and why sending officers with little background information is risky for everyone. The fix is coordination and clarity: share what you legally can, add a clinician to the response, and approach the door with a plan rooted in safety and rapport.Training is the force multiplier. Sarah breaks down how academy curricula evolved to center practical de-escalation and communication, then explains why the biggest gains come later with advanced, scenario-driven refreshers once officers have real street context. We talk tactics for engaging someone in psychosis without lying or escalating, why 988 is essential but not a complete substitute, and how blending 988, CIT, and co-response builds a smarter, safer safety net. We close with Sarah's work at William James College and the new Center for Crisis Response and Behavioral Health, designed to scale what works across departments and borders.If you care about first responder mental health, public safety, and better outcomes for people in crisis, this conversation offers a clear roadmap. Listen, share it with your team, and leave a review so more agencies can find these tools and put them to work in their communities.To reach Sarah, please visit her website at: https://www.abbottsolutionsforjustice.comSarah can also befound on LinkedIn at: https://www.linkedin.com/company/abbott-solutions-for-justice-llc/?viewAsMember=trueFreed.ai: We'll Do Your SOAP Notes!Freed AI converts conversations into SOAP note.Use code Steve50 for $50 off the 1st month!Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.Support the showYouTube Channel For The Podcast

How does long-term ADHD medication use impact heart health? In this webinar, Samuele Cortese, M.D., Ph.D., presents the latest research on cardiovascular problems and ADHD medication use, including considerations for older adults. Heart Health and Stimulant Use: Resources Free Download: What You Need to Know About ADHD Medication Read: Change of Heart: Understanding Cardiovascular Disease in Women with ADHD Read: Who's Afraid of ADHD Stimulants? Watch: How ADHD Affects Life Expectancy Access the video and slides for podcast episode #588 here: https://www.additudemag.com/webinar/cardiovascular-risk-adhd-medication-stimulants-heart-health/ Thank you for listening to ADDitude's ADHD Experts podcast. Please consider subscribing to the magazine (additu.de/subscribe) to support our mission of providing ADHD education and support.